LGC SeraCare, a brand name for LGC Clinical Diagnostics Inc, has been advancing the development of clinical genomics, molecular and serological diagnostics with innovative technology, quality controls, reagents and biological materials since 1984. They offer a broad selection of highly multiplexed, patient-like reference materials with clinically relevant DNA and RNA variants that are manufactured in cGMP-compliant, ISO 13485-certified facilities.
Seraseq™ NGS Reference Materials
Seraseq NGS reference materials provide a consistent and reliable positive and negative control material for next generation sequencing (NGS) assay development, validation, clinical deployment, lot-to-lot testing, in-kit controls and daily run control QC. They are formatted as purified DNA (gDNA), purified circulating tumor DNA (ctDNA), synthetic plasma-like material, as well as formalin-fixed, paraffin-embedded (FFPE) material.
Cambridge Bioscience is pleased to provide LGC SeraCare products in the UK.